MediPharm Labs Corp. (TSX:LABS)
0.0600
+0.0050 (9.09%)
Nov 20, 2026, 4:00 PM EST
MediPharm Labs Revenue
MediPharm Labs had revenue of 11.80M CAD in the quarter ending September 30, 2026, with 3.09% growth. This brings the company's total for the last twelve months to 41.81M, down -9.31% year-over-year. In the year 2025, MediPharm Labs had annual revenue of 45.12M with 7.54% growth. That makes MediPharm Labs the 31,621st largest company in the world by revenue and 563rd in Canada.
Revenue (ttm)
41.81M
Revenue Growth
-9.31%
P/S Ratio
0.61
Revenue / Employee
329.22K
Employees
127
Market Cap
25.63M
Revenue by Geography
- Canada 19.76M 43.8%
- Germany 12.01M 26.6%
- Australia 10.72M 23.8%
- Other 2.64M 5.9%
Fiscal year ended Dec 31, 2025 See the full MediPharm Labs breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.12M | 3.16M | 7.54% |
| Dec 31, 2024 | 41.96M | 8.90M | 26.92% |
| Dec 31, 2023 | 33.06M | 10.95M | 49.49% |
| Dec 31, 2022 | 22.12M | 406.00K | 1.87% |
| Dec 31, 2021 | 21.71M | -14.30M | -39.71% |
| Dec 31, 2020 | 36.01M | -93.24M | -72.14% |
| Dec 31, 2019 | 129.25M | 119.05M | 1,167.42% |
| Dec 31, 2018 | 10.20M | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 201.76M |
| Planet 13 Holdings | 130.97M |
| Rubicon Organics | 66.86M |
| LSL Pharma Group | 41.83M |
| Medicure | 32.08M |
| ZYUS Life Sciences | 374.00K |
| Optimi Health | 175.67K |
MediPharm Labs News
- 8 days ago - MediPharm Labs Earnings Call Transcript: Q3 2026 - Transcripts
- 8 days ago - MediPharm Labs Report: Q3 2026 - Filings
- 8 days ago - MediPharm Labs MD&A: Q3 2026 - Filings
- 8 days ago - MediPharm Labs Earnings release: Q3 2026 - Filings
- 8 days ago - MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth - GlobeNewsWire
- 10 days ago - MediPharm Labs Expands Brazilian Business with Commercial Launch of ANVISA-Authorized Cannabis Extract Oil - GlobeNewsWire
- 14 days ago - MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results - GlobeNewsWire
- 15 days ago - MediPharm Labs Achieves Critical European Regulatory Milestone Supporting Commercialization of Proprietary Metered-Dose Cannabis Inhaler Platform - GlobeNewsWire